ARCADOPHTA
FR-MF-000001661 · France · TOULOUSE
ARCADOPHTA is registered in the European database on medical devices as a manufacturer, with 9 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIb | 8 |
|---|---|
| Class IIa | 1 |
Among these devices, 9 are declared sterile, 8 implantable.
Devices declared under this manufacturer
- ARCEOLE C2F6
- ARCEOLE C3F8
- ARCEOLE SF6
- ARCIOLANE 1300 Syringe
- ARCIOLANE 1300 Syringe 15mL
- ARCIOLANE 1300 Vial
- ARCIOLANE 5500 Syringe
- ARCIOLANE 5500 Vial
- OP'COVER
Catalogue references include 201, 202, 203, 204, 205, 301.
European nomenclature codes declared: Q02030202, Q02030199, Q02030399.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 9 |
| Country of registration | France |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 9 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Licensed in Canada |
|---|---|
| Matched entry | ARCADOPHTA |
North American profile: Canada only. ARCADOPHTA holds a Canadian licence but was not found in the U.S. register.